While these executives and directors bring tremendous pharmaceutical and vaccine experience to Oragenics, we have also engaged advisors to help us navigate research and development, manufacturing, and regulatory pathways.
Terrence (Terry) Cochrane
Terrence (Terry) Cochrane is President of BrevisRefero Corporation in Ontario, Canada. Mr. Cochrane brings decades of life sciences industry experience to Oragenics, with over 20 years of progressive management experience in biopharmaceutical development and the GMP manufacturing industry for biologic therapies and vaccines. BrevisRefero provides biopharma outsourcing assistance in identifying and selecting service providers and follow-on technical program management to facilitate the delivery of products to clinic and market. Mr. Cochrane holds a B.S. from the University of Winnipeg in Biochemistry and Biology.
Timothy Cooke, Ph.D.
Dr. Cooke has more than 30 years of vaccine development experience in early- to late-stage research and development programs. Dr. Cooke’s experience includes 20 years at Merck, where he helped to develop several blockbuster vaccines. Dr. Cooke has been a vaccine development consultant to MNCs, small biotechs and NGOs around the world for more than 10 years.
David Zarley, PhD
Dr. David Zarley has more than 30 years of experience in vaccine research and development in the private sector, including as a consultant to Noachis Terra. Dr. Zarley was Vice President of Program Management for Vaccine Research and Development at Pfizer and Senior Director and Medicines Team Leader for the Pfizer Primary Care Business Unit. Dr. Zarley was also Senior Director for the Wyeth Research Project Management Business Unit and Senior Director for Technical Operations and Product Supply at Wyeth Vaccines. Dr. Zarley’s experience also includes work as a Senior Research Biochemist and Project Leader for Viral Vaccine Research and Development at Lederle-Praxis Biologicals. Dr. Zarley received his PhD in Molecular, Cellular, and Development Biology from Indiana University.
James P. Kelly, MA, MD, FAAN, FANA
Dr. Kelly is the Executive Director of the Marcus Institute for Brain Health (MIBH) and Professor of Neurology at the University of Colorado Anschutz Medical Campus in Aurora, CO. The MIBH is a specialized treatment program funded by the Marcus Foundation to care for US military Veterans with persistent symptoms of TBI. He is also National Director of the Gary Sinise Foundation Avalon Network TBI Medical Programs for which the MIBH serves as the clinical coordinating center.
His immediate past position was Director of the National Intrepid Center of Excellence (NICoE) at Walter Reed National Military Medical Center in Bethesda, MD. As its founding Director, he led the creation of an innovative interdisciplinary team of healthcare professionals who blended high-tech diagnosis and treatment with complementary and alternative medical interventions in a holistic, integrative approach to the care of U.S. military personnel with the complex combination of TBI and psychological conditions such as post-traumatic stress, depression, and anxiety. In this role, Dr. Kelly was frequently called upon by leaders of the Military Health System in the Pentagon, the U.S. Congress, the Department of Veterans Affairs, and numerous military facilities in the continental U.S. and abroad. He twice traveled to Afghanistan to advise and assist at military hospital programs and forward operating base medical units.